JESSICA RAINEY: Open Payments
NPI 1831817204 · FLORENCE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,046 in 118 payments from 19 companies in 2025. Trend: 2023 $1,652 · 2024 $1,896 · 2025 $2,046
Food & beverage: $2,046
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 28 | $300 |
| AstraZeneca Pharmaceuticals LP | 7 | $227 |
| Novo Nordisk Inc | 13 | $212 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 10 | $200 |
| Axsome Therapeutics, Inc. | 8 | $198 |
| Lilly USA, LLC | 10 | $163 |
| Phathom Pharmaceuticals, Inc. | 9 | $125 |
| Otsuka America Pharmaceutical, Inc. | 4 | $94 |
| PFIZER INC. | 6 | $91 |
| Astellas Pharma US Inc | 4 | $90 |
Products named: CAPLYTA, AIRSUPRA, VRAYLAR, Wegovy, VOQUEZNA, Symbravo, REXULTI, QULIPTA.
Industry payments across AL — which companies pay providers there.
